Seha Virtual Hospital has announced the successful completion of a groundbreaking clinical study that confirms the effectiveness of the AI-driven platform iSelfie.ai in the early identification of heart disease and related chronic conditions. This research, conducted at the Digital Clinical Research Center, involved over 1,000 participants and received necessary approvals from the Saudi Food and Drug Authority and the Research and Studies General Department, as reported by the Saudi Press Agency.
The clinical trial, which was carried out in partnership with prominent national medical institutions, emphasizes the significance of collaborative efforts in enhancing medical research within the Kingdom. The primary objective of the study was to assess the accuracy of the iSelfie.ai platform, developed in Canada, which leverages artificial intelligence to analyze selfies taken with standard smartphone cameras. This innovative technology can quickly measure vital signs, including blood pressure, heart rate, oxygen saturation, and respiratory rate.
Findings from the study indicated that the accuracy of iSelfie.ai is on par with conventional medical devices, establishing it as a rapid, cost-effective tool for early diagnosis. Previous clinical trials conducted in the United States, Canada, and Brazil have also yielded promising results for this technology, according to the Saudi Press Agency.
The Digital Clinical Research Center, inaugurated during last year”s Global Health Exhibition, remains committed to advancing healthcare through five pioneering digital studies that incorporate artificial intelligence, wearable technologies, and telemedicine. This initiative aligns with the strategic vision aimed at expediting treatment innovations, fostering research advancements, and equipping healthcare professionals with cutting-edge tools, thereby improving patient safety and overall quality of life in accordance with the health transformation goals of Vision 2030.
